由内源生物化学逻辑编程的自主水凝执行器,用于双阶段形态和药物释放
Yuchen Liu1, Harischandra Potthuri1, Alejandro Sosnik1
1Department of Materials Science and Engineering, Technion Israel Institute of Technology, Haifa, Israel.
Advanced materials (Deerfield Beach, Fla.)
|January 22, 2026
概括
科学家们开发了一种3D打印的水凝执行器,可以自主改变形状,并在胃中释放药物. 这种生物反应性材料使用人体自身的酶进行有针对性的输送和控制.
科学领域:
- 生物医学系统工程 生物医学系统工程
- 材料科学 材料科学 材料科学
- 软机器人软机器人 软机器人软机器人
背景情况:
- 为生理环境设计自主软材料是一项挑战.
- 现有系统通常需要外部触发器或手动干预.
研究的目的:
- 创建一个3D打印的混合蛋白质聚合物凝执行器,具有自主,双阶段的功能.
- 为了使酶触发的药物释放在胃模拟环境中.
主要方法:
- 使用数字光处理 (DLP) 打印制造双层水凝执行器的制造.
- 使用牛血清蛋白多 (乙烯基醇) 二烯酸盐 (BSA-PEGDA) 作为活性层,PEGDA作为被动层.
- 调查依赖pH的胀和素介导的降解,以改变形状和释放药物.
主要成果:
- 执行器在对酸性胃液和素的反应中展示了自主,可逆的形状转换.
- 多克索鲁比 (DOX) 释放受到特定地点的控制,并可通过statin A 抑制调节.
- 3D打印使复杂的设计成为可能,包括用于粘膜粘附和受控分娩的微针抓手.
结论:
- 本文介绍了一种材料设计策略,使用生物化学线索进行可编程的机械和治疗输出.
- 开发的水凝执行器为生物响应软机器人和现场药物递送提供了一个强大的平台.
相关概念视频
Drugs Acting on Autonomic Ganglia: Stimulants
2.1K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.1K
Drugs Acting on Autonomic Ganglia: Blockers
1.6K
Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
1.6K
Drugs Affecting Neurotransmitter Release or Uptake
1.6K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.6K
In Vitro Drug Release Testing: Overview, Development and Validation
322
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
322
Autonomic Nervous System
12.3K
The autonomic nervous system (ANS) is a critical component of the peripheral nervous system, primarily responsible for regulating involuntary bodily functions and maintaining homeostasis. It functions in tandem with the central nervous system (CNS) to seamlessly coordinate various physiological processes without the need for conscious control.
The ANS comprises two main divisions: the sympathetic and parasympathetic divisions. These divisions function antagonistically to maintain a dynamic...
The ANS comprises two main divisions: the sympathetic and parasympathetic divisions. These divisions function antagonistically to maintain a dynamic...
12.3K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
849
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
849


